Abstract The endogenous or exogenous origin of Staphylococcus aureus, responsible for orthopaedic surgical-site infections (SSI), remains debated. We conducted a multicentre prospective cohort study to analyse the respective part of exogenous contamination and endogenous selfinoculation by S. aureus during elective orthopaedic surgery. The nose of each consecutive patient was sampled before surgery. Strains of S. aureus isolated from the nose and the wound, in the case of SSI, were compared by antibiotypes or pulsed-field gel electrophoresis (PFGE). A total of 3,908 consecutive patients undergoing orthopaedic surgery were included. Seventy-seven patients developed an SSI (2%), including 22 related to S. aureus (0.6%). S. aureus was isolated from the nose of 790 patients (20.2%) at the time of surgery. In the multivariate analysis, S. aureus nasal carriage was found to be a risk factor for S. aureus SSI in orthopaedic surgery. However, only nine subjects exhibiting S. aureus SSI had been found to be carriers before surgery: when compared, three pairs of strains were considered to be different and six similar. In most cases of S. aureus SSI, either an endogenous origin could not be demonstrated or pre-operative nasal colonisation retrieved a strain that was different from the one recovered from the surgical site
Introduction
The risk of prosthetic joint infection is less than 2% after joint replacement [1] [2] [3] or after the implantation of internal fracture-fixation devices [4] . However, the large number of such procedures performed annually makes these infections highly significant in terms of mortality, morbidity and costs, as far as the elderly population is increasing in industrialised countries [5] [6] [7] . It is a well-known fact that Staphylococcus aureus carriage predisposes to post-operative staphylococcal infection in general surgery [8] , in heart surgery [9, 10] , as well as in orthopaedic surgery [11] . However, Kalmeijer et al. [8] , in orthopaedic surgery, realised their study in only one centre, with a limited number of patients. Moreover, the studies showing a substantial reduction of surgical-site infections (SSI) among patients receiving mupirocin were all compared to historical controls [8, [12] [13] [14] , whilst Kalmeijer et al. [15] , in a double-blind, randomised, placebo-controlled study, in orthopaedic surgery, failed to show any beneficial effect. So, the exogenous pathway of contamination in orthopaedic surgery remains an important hypothesis and we undertook a large prospective multicentre cohort study in order to determine whether the nasal carriage of S. aureus is the main pathway responsible for infection in orthopaedic SSI.
Patients and methods
We conducted a prospective epidemiological multicentre observational study to estimate the relative part of subjects with S. aureus nasal carriage in patients with SSI following prosthetic and internal fracture-fixation device surgery, and in non-infected patients. We compared, in SSI patients, the strains of S. aureus colonising the anterior nares and those isolated from the site of infection.
Patients
All consecutive patients undergoing scheduled orthopaedic surgery with implantation of prosthesis or internal fracturefixation device in 17 centres (see "Study Group Members" at the end of this paper) were included from June 2003 to January 2007. A control visit was performed by the surgeon at least one month and one year after surgery. Exclusion criteria were non-programmed surgery and suspicion of infection at the site of surgery.
Written informed consent was obtained for all patients. The study protocol was approved by the regional ethical research committee (Comité de Protection des Personnes Rhône-Alpes I).
The preparation of the patients' skin included at least one pre-operative shower with a soap containing either chlorhexidine or polyvidone iodine, cleansing of the skin with an antiseptic soap followed by disinfection with an alcoholic antiseptic in the operative theatre. Antibiotic prophylaxis was done with cefazolin 2 g at the anaesthetic induction. Mupirocin nasal decontamination was not used regardless of the results of the sampling.
One to three months before surgery, the study was explained to the patient during surgical consultation. Written information was delivered. The nose of the patient was sampled at admission. To ensure good performance and reproducibility of the nasal sampling, nurses were trained and a written protocol was available in each participating unit. The patient's practitioner was informed of the study and asked to refer the patient to the surgeon if an SSI was suspected. In the latter case, at least three bacteriological samples were taken at the site of the suspected infection either per-operatively (without antimicrobial prophylaxis) or by aseptic aspiration using ultrasound guidance. Direct examination and bacteriological culture were systematically performed.
Bacteriological methods
For the nasal cultures, one swab was used to sample both nares and was plated onto sheep blood agar plate or onto specific S. aureus Chromastaph medium (bioMérieux, Marcy l'Etoile, France) within 24 h after sampling if a moistened transport medium was used (Transtube®, Medical Wire and Equipment Co., Corsham, England or Amies agar gel, Copan, Brescia, Italy) or within 2 h in the opposite case. Plates were incubated for up to 48 h at 36°C. The identification of S. aureus isolates and their sensitivity to antibiotics were determined by standard microbiological procedures.
As for nasal samples, swabs were cultured within 2 h after sampling if no transport medium was used and within 24 h in the opposite case. Fluid samples were examined by light microscopy after Gram staining. They were cultured both aerobically and anaerobically into blood culture bottles and monitored in an automated system. Solid samples were dissected into tiny pieces with a lancet in a safety cabinet and then ground down. The homogenate was cultured onto aerobic and anaerobic media. The media were incubated at 36°C for at least 48 h for plate cultures and 15 days for liquid broths.
In addition to phenotypic characteristics, all of the available pairs of strains of S. aureus isolated from the nose and the infected surgical site were compared by pulsed-field gel electrophoresis (PFGE) using SmaI. The available strains were centralised in a single laboratory where PFGE was performed. Plugs containing DNA were prepared following a rapid lysis procedure [16] . Bacterial cells from an overnight broth culture were mixed with 1.6% of SeaPlaque agarose (Cambrex, Rockland, ME, USA). The plugs were incubated in lysis buffer containing 250 IU of lysostaphin (AMBI Inc., Lawrence, NY, USA) for 2 h at 37°C, followed by a 1-h incubation at 50°C with ESP buffer containing 100 mg/L of proteinase K. Plugs were rinsed with TE buffer, incubated in TE with PMFS for 30 min at 37°C, before final washing in TE buffer. The genomic DNA inserts were digested at 25°C for 2 h with 20 UI of SmaI enzyme. The fragments were separated by PFGE with a CHEF-DRII apparatus (Biorad, Ivry sur Seine, France) in a 1.1% agarose gel (Gigaphor, Promega, Les Ulis, France) in TBE buffer, at 14°C under a field strength of 6 V/cm and a linear ramp of 1 s-28 s for 21 h.
Definitions
Nasal carriage of S. aureus Carriage was considered if a strain of S. aureus was recovered at one sampling. Patients without documented S. aureus carriage were classified non-carriers.
SSI
Definition for SSI were those s edited by the Centers for Disease Control (CDC) [17] .
Classification of pairs of S. aureus strains isolated from the nose and the SSI in the same patient For the same patient, according to Tenover's criteria [18] , two S. aureus strains were classified as epidemiologically distinct if a difference of more than three bands was ascertained between the PFGE profiles performed in a same run. When the S. aureus strain isolated from the surgical site was not available for typing, the antimicrobial patterns were used to compare the strains isolated in the same patient: a difference in antimicrobial susceptibility of two or more molecules indicated different strains; in case of differences concerning one or no antibiotic, strains were considered to be phenotypically similar.
Data recorded
The following variables were recorded for each patient: age, sex, body mass index (BMI), tobacco use, underlying diseases (malignancy, diabetes, malnutrition, immunodeficiency, renal deficiency), medications (particularly antibiotics one month before surgery and immunosuppressive drugs, such as corticosteroids), rheumatoid arthritis, kind of procedure performed and type of prosthesis, cement use, antimicrobial prophylaxis, date of admission to the hospital, date of surgery, date of discharge, dates of follow-ups, class of wound contamination, American Society of Anaesthesiologists (ASA) score, duration of surgery, prosthesis first implantation or revision, blood transfusion, haematologic diseases and notable blood collection after surgery. The data of nasal samplings and their results were also recorded. In case of SSI, the following data were collected: date of infection, localisation of infection (superficial or deep), clinical symptoms, microbiological identification and treatment.
Outcomes
The primary outcome was to identify risk factors of SSI due to S. aureus by using multivariate analysis with special emphasis on the variable "nasal carriage of S. aureus". The secondary outcomes were: (i) to evaluate the proportion of S. aureus strains isolated in the same patient from the nose and SSI found to be similar by microbiological methods, (ii) to estimate the frequency of S. aureus nasal carriage in our cohort of patients and (iii) to estimate the risk of S. aureus SSI.
Statistical analyses
We estimated that SSI would occur in 1% of hip prosthesis surgery and in 2% of knee prosthesis surgery, and that the proportion of S. aureus responsible for infection would be 40%. Overall, we calculated that 4,200 patients were needed for this study in order to detect a 20% difference of S. aureus nasal carriage between patients without and with SSI due to S. aureus, given a two-tailed alpha level of 5% and a statistical power of 80%. It was hypothesised that an attending number of 40 SSI due to S. aureus would give sufficient discriminative power to compare pairs of strains (nose and SSI) by molecular techniques.
The software used for the collection of the recorded data was Epi Info, version 6.04d Fr (CDC WHO). SPSS software, version 16.0 (Chicago, IL, USA) was used for univariate and multivariate analyses. Windows SAS® 9.1 software was used to adjust for cluster effect in the multivariate analysis. The rates of SSI and SSI due to S. aureus were calculated globally and according to patients' nasal carriage of S. aureus and to the type of device implemented. These rates were also stratified according to the National Nosocomial Infection Surveillance (NNIS) index.
Fisher's exact test was used for the analysis of categorical variables. The Wilcoxon non-parametric test was used for mean comparisons. Two multivariate analyses were carried out to evaluate (i) risk factors for SSI and (ii) risk factors for SSI due to S. aureus. To adjust for confounding factors, variables with a p-value below the 0.05 significance level in the univariate analysis were entered into a multiple logistic regression model. Because of the low number of SSI infections, the multivariate analysis was run with a maximum of three covariates selected among the most significant in the univariate analyses. p-values below the 5% level were considered to be statistically significant.
Results

Demographic and clinical data
The total duration of the study was 4 years (3 years of inclusion and 1 year of supplementary follow-up, ending January 2008). A total of 4,046 patients were included and 3,908 (96.6%) patients were evaluated. The demographic characteristics of the patients are shown in Table 1 . The causes for exclusion (138 patients) are described in Fig. 1 . Seventy-seven patients (2%) were considered as victims of SSI. The overall infection rate was 2.2% for total hip replacement, 1.7% for knee replacement and 1.6% for partial prosthesis and fracture-fixation devices.
Microbiological data
The most common infecting micro-organisms were coagulase-negative Staphylococcus spp. (0.9% of patients), followed by S. aureus (0.6%) and Gram-negative bacteria (0.4%). Of these infections, 61% arose in the first 3 months following surgery. There was no significant change in the infection rate or type of infecting micro-organism over the course of the study. As shown in Table 2 , 94 microorganisms were found to be responsible for SSI. Fourteen SSI were polymicrobial.
Twenty-two SSI due to S. aureus were documented; 13 of these patients were classified as nasal non-carriers and nine as nasal carriers.
Within the strains isolated from the 13 patients classified as nasal non-carriers, eight were available for typing by PFGE. All of these strains exhibited independent profiles (data not shown). The five remaining strains were isolated from patients hospitalised in five different centres, excluding cross-transmission.
In patients classified as nasal carriers, the nine pairs of strains isolated from SSI and nasal specimens were compared according to their genotype (four cases) and/or their antimicrobial susceptibility (five cases). From the four pairs of strains compared by PFGE, two pairs exhibited different profiles, whereas two other pairs were shown to share a similar profile according to Tenover's criteria (Fig. 2) . All of these strains were different from those isolated from infected patients classified as non-carriers (data not shown). For the five remaining cases, nasal samples were not available for typing in two cases and, in three cases, strains recovered from the surgical site were not stored because they were isolated in laboratories located outside a university hospital; when compared according to antibiotypes, one of these five pairs was classified to be different, whereas the remaining four were classified as similar because of identical or minor differences in antimicrobial susceptibility (see footnotes of Table 3 for details). Overall, by combining the results of genotypic and phenotypic typing methods, from a total of 22 S. aureus SSI, no S. aureus nasal carriage was noted in 13 patients; in the nine remaining patients, three pairs of strains were different and six pairs were similar (Table 3) . So, with the hypothesis of maximum bias, at least 16 of the 22 cases of S. aureus SSI were independent of nasal carriage of S. aureus at the time of surgery. SSI and nasal carriage S. aureus was isolated in the nose of 790 patients at the time of surgery (20.2%). Methicillin-resistant S. aureus (MRSA) strains were isolated in only 0.6% of patients. The overall risk of SSI was measured at 2% (95% CI [1.6-2.4], range 0-7.6 according to the centre). The prevalence of SSI due to S. aureus was 0.6% (95% CI [0.36-0.84]).
Risk factors for SSI
Univariate and multivariate analyses were performed to assess the risk factors for SSI ( Fig. 1 Frequency of surgicalsite infection (SSI) according to the type of prosthesis implemented haematoma and NNIS score for the occurrence of SSI, and nasal carriage together with tobacco use and NNIS score for SSI due to S. aureus (Table 4) .
Discussion
The present study is, to our knowledge, the largest evaluation of the nasal carriage of S. aureus in patients undergoing orthopaedic surgery. It confirms that nasal carriage of S. aureus at the time of surgery is a risk factor for S. aureus SSI in orthopaedic surgery. However, 13 out of 22 S. aureus SSI occurred in non-carriers, and the majority (16/22) of S. aureus SSI were independent of nasal carriage, suggesting an exogenous pathway of contamination. Recently, two studies performed in cardiothoracic surgery [19] and in general surgery [20] showed that endogenous nasal contamination was the major acquisition pathway for methicillin-susceptible S. aureus (MSSA), whereas an exogenous acquisition pathway was essential for methicillin-resistant S. aureus (MRSA), underlining the crucial role of hospital infection control measures.
Several criticisms can be addressed regarding our study. First, we have limited the sampling to the anterior nares, since this site is considered to be the primary colonisation site of S. aureus [21, 22] . Recently [23] , a large study has highlighted the importance of the throat as a significant site of S. aureus carriage, with an additional sensitivity of 25.7% when combined with nasal sampling. It confirmed, however, that the anterior nares are the most colonised sites with S. aureus. Our protocol included initially a rectal swabbing before surgery; however, since many patients denied this sample, the data regarding rectal specimens could not be taken into consideration. With a single nasal sample, and in the absence of additional throat and rectal specimens, the frequency of carriage of S. aureus in our cohort was certainly underestimated, as illustrated by the figure of 20.2% of nasal carriers in this study compared to 37.1% in that of Mertz et al. [23] , which combined nasal and throat samplings. Second, we obtained only one qualitative (and not quantitative) nasal sample from each patient. However, the most predictive factor for S. aureus infections is the persistent carriage pattern [24] . Collecting up to seven nasal swab cultures to accurately segregate non-carriers from intermittent carriers, as suggested by Nouwen et al. [25] , was not practically feasible for such a large effective study population. Indeed, most S. aureus screening programmes require only one swabbing of the anterior nares [8, 13, 15] . Third, with an end-point at 1 year after the device implantation, we missed late infections (>2 years) [26] . However, the latter infections are not systematically attributed to a per-operative contamination and are mostly caused by organisms other than S. aureus [4] . Fourth, and this is the major weakness of our study, many strains of S. aureus were not available for molecular typing because infection was often detected outside the surgical setting and the corresponding laboratory omitted to keep the strain.
Despite these criticisms, in our study, with the hypothesis of maximum bias, at least 16 of the 22 cases of S. aureus SSI were not related to S. aureus nasal 
Patient
Isolate Profile * * * Fig. 2 SmaI pulsed-field gel electrophoresis (PFGE) profiles of strains of Staphylococcus aureus isolated from four patients for whom the nasal isolate(s) and the surgical site isolate(s) were available. The strain of S. aureus NTCC 8322 was used as a size marker. The asterisk indicates the reference size marker; N = nasal strain; I = isolate from SSI; S = isolate from stools Positive ( carriage before surgery. The origin of S. aureus may be another site of carriage, such as the throat [23] , perineum or digestive tract [27, 28] . Indeed, throat or intestinal carriage without nasal carriage occurs relatively frequently [23, 27] , which can provide a rationale to investigate this reservoir for the endogenous origin of S. aureus infection. Orthopaedic SSI can also result from exogenous transmission, as has been already shown, notably from the hospital environment and from health-care workers [29, 30] . It is noteworthy that, in our study, no cross-transmission of S. aureus within centres was documented. Our results could explain why in general surgery [9] and in orthopaedic surgery [15] , randomised controlled trials with mupirocin, eliminating solely the nasal carriage, were unable to reduce S. aureus SSI. Concerning the strategies to prevent SSI, in the more recent SHEA/IDSA practice recommendations, the routine screening for S. aureus carriage or attempts to decolonise surgical patients with an antistaphylococcal agent in the pre-operative setting remains unsolved issues [31] .
In conclusion, the nasal carriage of S. aureus at the time of surgery, as investigated in this study, is a risk factor for S. aureus SSI in orthopaedic surgery. However, screening for S. aureus of the nares only did not reliably predict S. aureus SSI. In most cases of S. aureus SSI, either an endogenous origin could not be demonstrated or preoperative nasal colonisation retrieved a strain that was different from the infecting pathogen. Further studies are necessary to elucidate the role of extra-nasal S. aureus carriage and the potential role of exogenous sources of contamination in elective orthopaedic surgery. As pointed out by our results, non-S. aureus nasal carriers must also be taken into account, arguing for the importance of implementing robust standard prevention strategies for SSI.
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